title: C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.
abstract: The clinical relevance of gene therapy using the recombinant adeno-associated virus (rAAV) vectors often requires widespread distribution of the vector, and in this case, systemic delivery is the optimal route of administration. Humoral blood factors, such as antibodies or complement, are the first barriers met by the vectors administered systemically. We have found that other blood proteins, galectin 3 binding protein (G3BP) and C-reactive protein (CRP), can interact with different AAV serotypes in a species-specific manner. While interactions of rAAV vectors with G3BP, antibodies, or complement lead to a decrease in vector efficacy, systemic transduction of the CRP-deficient mouse and its respective control clearly established that binding to mouse CRP (mCRP) boosts rAAV vector 1 (rAAV-1) and rAAV-6 transduction efficiency in skeletal muscles over 10 times. Notably, the high efficacy of rAAV-6 in CRP-deficient mice can be restored by reconstitution of the CRP-deficient mouse with mCRP. Human CRP (hCRP) does not interact with either rAAV-1 or rAAV-6, and, consequently, the high efficiency of mCRP-mediated muscle transduction by these serotypes in mice cannot be translated to humans. No interaction of mCRP or hCRP was observed with rAAV-8 and rAAV-9. We show, for the first time, that serum components can significantly enhance rAAV-mediated tissue transduction in a serotype- and species-specific manner. Bioprocessing in body fluids should be considered when transfer of a preclinical proof of concept for AAV-based gene therapy to humans is planned.
authors.affiliation: Genethon, Evry, France.
authors.forename: Jerome
authors.initials: J
authors.lastname: Denard
authors.forename: Beatrice
authors.initials: B
authors.lastname: Marolleau
authors.forename: Christine
authors.initials: C
authors.lastname: Jenny
authors.forename: Tata Nageswara
authors.initials: TN
authors.lastname: Rao
authors.forename: Hans Jörg
authors.initials: HJ
authors.lastname: Fehling
authors.forename: Thomas
authors.initials: T
authors.lastname: Voit
authors.forename: Fedor
authors.initials: F
authors.lastname: Svinartchouk
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002097:C-Reactive Protein / Q000502:physiology*; D000229:Dependovirus / Q000145:classification / Q000235:genetics*; D005822:Genetic Vectors / Q000008:administration & dosage*; D006801:Humans; D047468:Immunoprecipitation; D008156:Luciferases / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014161:Transduction, Genetic
chemical_list: D012333:RNA, Messenger; D002097:C-Reactive Protein; D008156:Luciferases
references.citation: Structure. 1999 Feb 15;7(2):169-77
references.pmid: 10368284
references.citation: J Biol Chem. 2005 Jul 1;280(26):25095-102
references.pmid: 15878871
references.citation: Clin Transl Sci. 2010 Jun;3(3):81-9
references.pmid: 20590676
references.citation: J Virol. 2012 Jun;86(12):6620-31
references.pmid: 22496229
references.citation: J Virol. 2006 Sep;80(18):9093-103
references.pmid: 16940521
references.citation: J Biol Chem. 2011 Apr 15;286(15):13532-40
references.pmid: 21330365
references.citation: Nat Biotechnol. 2010 Jan;28(1):79-82
references.pmid: 20037580
references.citation: Hum Gene Ther. 2006 Jan;17(1):10-9
references.pmid: 16409121
references.citation: Nat Struct Biol. 1996 Apr;3(4):346-54
references.pmid: 8599761
references.citation: Adv Intern Med. 1992;37:313-36
references.pmid: 1558000
references.citation: Mol Ther. 2008 Jun;16(6):1073-80
references.pmid: 18414476
references.citation: J Exp Med. 1930 Sep 30;52(4):573-85
references.pmid: 19869789
references.citation: Mol Ther. 2011 Jun;19(6):1079-89
references.pmid: 21364543
references.citation: J Immunol. 2001 Mar 15;166(6):3998-4004
references.pmid: 11238646
references.citation: Gene Ther. 2013 May;20(5):497-503
references.pmid: 22855092
references.citation: Nature. 2006 Apr 27;440(7088):1217-21
references.pmid: 16642000
references.citation: Hum Gene Ther. 2010 Jun;21(6):704-12
references.pmid: 20095819
references.citation: Gene Ther. 2008 Jun;15(11):808-16
references.pmid: 18385765
references.citation: Virology. 2009 Mar 15;385(2):434-43
references.pmid: 19144372
references.citation: Hum Gene Ther. 2009 Jul;20(7):698-706
references.pmid: 19438300
references.citation: J Virol. 2012 Oct;86(19):10408-17
references.pmid: 22787229
references.citation: J Virol. 1998 Feb;72(2):1438-45
references.pmid: 9445046
references.citation: J Virol. 2008 Mar;82(6):2727-40
references.pmid: 18199646
references.citation: J Virol. 2005 Jan;79(1):609-14
references.pmid: 15596854
references.citation: Proc Soc Exp Biol Med. 1971 Feb;136(2):612-4
references.pmid: 4395924
references.citation: J Virol. 2006 Oct;80(19):9831-6
references.pmid: 16973587
references.citation: J Biol Chem. 2011 Feb 25;286(8):6272-9
references.pmid: 21149301
references.citation: J Immunol. 2012 Jun 15;188(12):6418-24
references.pmid: 22593612
references.citation: J Immunol. 2000 Feb 1;164(3):1514-20
references.pmid: 10640769
references.citation: J Biol Chem. 2003 Nov 21;278(47):46974-82
references.pmid: 12960167
references.citation: J Immunol. 1995 Aug 15;155(4):2185-93
references.pmid: 7636267
references.citation: J Immunol. 2001 Jan 15;166(2):1200-5
references.pmid: 11145702
references.citation: J Virol. 2001 Aug;75(15):6884-93
references.pmid: 11435568
references.citation: Gene Ther. 2012 Apr;19(4):375-84
references.pmid: 21776025
references.citation: J Immunol Methods. 1978;23(1-2):59-67
references.pmid: 359713
references.citation: Gene. 2001 Nov 14;279(1):99-108
references.pmid: 11722850
references.citation: J Virol. 2003 Feb;77(4):2768-74
references.pmid: 12552020
references.citation: J Virol. 2000 Mar;74(6):2777-85
references.pmid: 10684294
references.citation: J Immunol. 1986 Mar 15;136(6):2202-7
references.pmid: 3950412
references.citation: J Gene Med. 2001 Jan-Feb;3(1):59-71
references.pmid: 11269337
references.citation: J Clin Invest. 2003 Jun;111(12):1805-12
references.pmid: 12813013
references.citation: J Mol Cell Cardiol. 2004 Mar;36(3):405-10
references.pmid: 15010279
references.citation: Exp Hematol. 2010 Sep;38(9):707-17
references.pmid: 20447441
references.citation: Hum Gene Ther. 1999 Jul 20;10(11):1885-91
references.pmid: 10446928
references.citation: Circulation. 2000 Oct 31;102(18):2165-8
references.pmid: 11056086
references.citation: Nat Med. 2006 Jul;12(7):787-9
references.pmid: 16819550
references.citation: Hum Gene Ther. 2010 Dec;21(12):1741-7
references.pmid: 20545554
references.citation: J Virol. 2006 Nov;80(22):11393-7
references.pmid: 16943302
references.citation: J Vis Exp. 2011 Mar 22;(49):
references.pmid: 21445055
references.citation: Mol Ther. 2008 Apr;16(4):657-64
references.pmid: 18334986
references.citation: J Biol Chem. 2004 Nov 19;279(47):48487-90
references.pmid: 15337754
references.citation: Biochem Biophys Res Commun. 1988 Oct 31;156(2):814-22
references.pmid: 3190681
references.citation: Int Immunol. 1993 Aug;5(8):957-64
references.pmid: 8398989